When and how do patients with cardiac amyloidosis die?-Reference-Cited by-同舟云学术

When and how do patients with cardiac amyloidosis die?

Published:2019-05-27 Issue:1 Volume:109 Page:78-88
ISSN:1861-0684
Container-title:Clinical Research in Cardiology
language:en
Short-container-title:Clin Res Cardiol

Author:

Escher F.,Senoner M.,Doerler J.,Zaruba M. M.,Messner M.,Mussner-Seeber C.,Ebert M.,Ensinger C.,Mair A.,Kroiss A.,Ulmer H.,Schneiderbauer-Porod S.,Ebner C.,Poelzl G.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00392-019-01490-2.pdf

Reference35 articles.

1. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kuhl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A (2008) Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29:270–276

2. Rapezzi C, Merlini G, Quarta CC, Riva L, Longhi S, Leone O, Salvi F, Ciliberti P, Pastorelli F, Biagini E, Coccolo F, Cooke RM, Bacchi-Reggiani L, Sangiorgi D, Ferlini A, Cavo M, Zamagni E, Fonte ML, Palladini G, Salinaro F, Musca F, Obici L, Branzi A, Perlini S (2009) Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 120:1203–1212

3. Pinney JH, Smith CJ, Taube JB, Lachmann HJ, Venner CP, Gibbs SD, Dungu J, Banypersad SM, Wechalekar AD, Whelan CJ, Hawkins PN, Gillmore JD (2013) Systemic amyloidosis in England: an epidemiological study. Br J Haematol 161:525–532

4. Dardiotis E, Koutsou P, Papanicolaou EZ, Vonta I, Kladi A, Vassilopoulos D, Hadjigeorgiou G, Christodoulou K, Kyriakides T (2009) Epidemiological, clinical and genetic study of familial amyloidotic polyneuropathy in Cyprus. Amyloid 16:32–37

5. Damy T, Costes B, Hagege AA, Donal E, Eicher JC, Slama M, Guellich A, Rappeneau S, Gueffet JP, Logeart D, Plante-Bordeneuve V, Bouvaist H, Huttin O, Mulak G, Dubois-Rande JL, Goossens M, Canoui-Poitrine F, Buxbaum JN (2016) Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness. Eur Heart J 37:1826–1834

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First report of the clinical characteristics and outcomes of cardiac amyloidosis in Saudi Arabia;ESC Heart Failure;2024-09

2. Kidney Transplant Outcomes in Amyloidosis: US National Database Study;Transplantation;2024-08-28

3. Arrhythmic Risk Stratification in Cardiac Amyloidosis: A Review of the Current Literature;Journal of Cardiovascular Development and Disease;2024-07-14

4. A patient with AL amyloidosis presenting with refractory tuberculosis, chest tightness and hypotension: case report;BMC Pulmonary Medicine;2024-07-02

5. Cardiac amyloidosis is not a single disease: a multiparametric comparison between the light chain and transthyretin forms;ESC Heart Failure;2024-05-16